According to a new report by Univdatos, Adeno-Associated Virus Gene Therapy Market, is expected to reach USD 70 Billion in 2032 by growing at a CAGR of 39%. Adeno-Associated Virus (AAV) gene therapy has emerged as a groundbreaking approach in the treatment of various genetic and acquired disorders. In the United States, the field has seen remarkable advancements, with numerous clinical trials...